ME/CFS Consolidation Call 2026
The call “ME/CFS Call 2026 - Consolidation” invited collaborative consortia to advance critical knowledge in post-acute infectious diseases, with particular emphasis on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), through innovative projects that push the boundaries of current understanding in etiopathogenesis, diagnostics, and therapeutic interventions.
Contact person: Benjamin Missbach
Funding volume: € 1.999.099
Number of applications: 6
Awarding procedure: Jury
Jury meeting: 10.9.2026
Formal decision by WWTF Board of Directors: 7.10.2026
Chris Ponting (Chair) | University of Edinburgh, UK
Alba Azola | Johns Hopskins Hospital, US
Resia Pretorius |Stellenbosch University, SA
Elisa Oltra | Catholic University of Valencia, ES
Rob Wüst | Vrije Universiteit (VU) Amsterdam, US
Keith Geraghty | University of Manchester, UK
Funded projects
- ME-CFS-CC26-003 Matthias Wielscher (Medical University of Vienna)
Rare Variant and Epigenomic Analysis in ME/CFS
Duration: 36 months, Funding volume: € 999,169 - ME-CFS-CC26-004 Lukas Haider (Medical University of Vienna, Department of Biomedical Imaging and Image-guided Therapy)
Mechanism-based Reversibility Evaluation and Stratified Endophenotyping of Treatment-response in ME/CFS
Duration: 36 months, Funding volume: € 999,930